Eric Holland

Eric Holland, MD, PhD is Senior Vice President and Director of the Human Biology Division at Fred Hutchinson Cancer Center, where he also holds the Endowed Chair in Cancer Biology. He directs Seattle Translational Tumor Research across Fred Hutch, UW Medicine, and Seattle Children's, and is a member of the Immunotherapy Integrated Research Center. As a neurosurgeon-scientist, he specializes in glioblastoma treatment and research.

His educational background includes:

• MD from Stanford University (1990)
• PhD in Biochemistry and Molecular Biology from University of Chicago (1985)

Holland's research revolutionized brain tumor understanding through genetically accurate mouse models, revealing glioblastoma as multiple molecularly distinct diseases rather than a single entity. His work focuses on tumor microenvironment interactions, stem-like cell resistance mechanisms, and developing novel therapies targeting pathways like Akt and YAP1. The lab combines molecular biology, neurosurgery, and computational modeling to advance glioma treatment.

Holland's publications demonstrate evolving focus from foundational mouse model development to molecular subtyping, immunotherapy response, and clinical translation. Recent work emphasizes ancient gene mechanisms in cancer, YAP1 fusions, and data-driven risk communication.

His leadership spans:

• Human Biology Division oversight
• Seattle Translational Tumor Research initiative
• Oncoscape data platform development
• TRACER rare cancer program

The Holland Lab maintains preclinical trial infrastructure using MRI and bioluminescence imaging, with active work on PDGFR inhibition strategies, TrkB splice variants, and mathematical modeling of tumor evolution. Current efforts prioritize molecularly-stratified clinical trials based on glioma subgroup biology.